Cargando…
Indolepropionic Acid, a Gut Bacteria-Produced Tryptophan Metabolite and the Risk of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
An intricate relationship between gut microbiota, diet, and the human body has recently been extensively investigated. Gut microbiota and gut-derived metabolites, especially, tryptophan derivatives, modulate metabolic and immune functions in health and disease. One of the tryptophan derivatives, ind...
Autores principales: | Sehgal, Ratika, de Mello, Vanessa D., Männistö, Ville, Lindström, Jaana, Tuomilehto, Jaakko, Pihlajamäki, Jussi, Uusitupa, Matti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653718/ https://www.ncbi.nlm.nih.gov/pubmed/36364957 http://dx.doi.org/10.3390/nu14214695 |
Ejemplares similares
-
Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals
por: Tuomainen, Marjo, et al.
Publicado: (2018) -
Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study
por: de Mello, Vanessa D., et al.
Publicado: (2017) -
RF28 | PSUN301 Sex Differences in the Indolepropionic Acid Alterations in Response to Obesity Surgery
por: Silva, Thaís R, et al.
Publicado: (2022) -
Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis
por: Sehgal, Ratika, et al.
Publicado: (2021) -
Serum Levels of Plasmalogens and Fatty Acid Metabolites Associate with Retinal Microangiopathy in Participants from the Finnish Diabetes Prevention Study
por: de Mello, Vanessa Derenji, et al.
Publicado: (2021)